Northern Trust Corp Repare Therapeutics Inc. Transaction History
Northern Trust Corp
- $761 Billion
- Q3 2025
A detailed history of Northern Trust Corp transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Northern Trust Corp holds 262,201 shares of RPTX stock, worth $432,631. This represents 0.0% of its overall portfolio holdings.
Number of Shares
262,201
Previous 286,010
8.32%
Holding current value
$432,631
Previous $397,000
16.12%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding RPTX
# of Institutions
51Shares Held
30.3MCall Options Held
158KPut Options Held
0-
Bvf Inc San Francisco, CA10.3MShares$17.1 Million0.98% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.44MShares$5.68 Million2.63% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.32MShares$5.48 Million0.2% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$4.9 Million17.66% of portfolio
-
Versant Venture Management, LLC San Francisco, CA2.65MShares$4.37 Million7.6% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $69.2M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...